Skip to main content
Year archive

SHINPOONG PHARMACEUTICAL CO.,LTD — 2021 filings

All 26 regulatory filings released by SHINPOONG PHARMACEUTICAL CO.,LTD (019170) in 2021, sourced directly from the official regulator.

26 Filings
2021 Period
2021 filings (26)
Filing Released Lang
풍문또는보도에대한해명(미확정)
Legal Proceedings Report
2021-11-24 Korean
분기보고서 (2021.09)
Interim / Quarterly Report 9M 2021
2021-11-15 Korean
투자판단관련주요경영사항
Regulatory Filings
2021-08-27 Korean
반기보고서 (2021.06)
Interim / Quarterly Report H1 2021
2021-08-17 Korean
투자판단관련주요경영사항(COVID-19 치료제 피라맥스정의 임상 3상 시험계획 승인 신청)
Regulatory Filings
2021-07-05 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-07-02 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Q1 2021
2021-05-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-05-07 Korean
최대주주등소유주식변동신고서
Director's Dealing
2021-04-27 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-04-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-04-27 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-04-07 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2021-03-31 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2021-03-31 Korean
사업보고서 (2020.12)
Annual Report FY 2020
2021-03-23 Korean
감사보고서제출
Audit Report / Information FY 2020
2021-03-22 Korean
투자판단관련주요경영사항(골관절염 주사요법제 SP5M001주의 임상3상 시험계획 승인)
Regulatory Filings
2021-03-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-03-12 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release FY 2020
2021-03-05 Korean
주주총회소집결의
AGM Information
2021-03-05 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2021-03-05 Korean
주주총회집중일개최사유신고
AGM Information
2021-03-05 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2021-03-05 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release FY 2020
2021-02-10 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2021-02-10 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2021-01-18 Korean